Flesinoxan
From Wikipedia, the free encyclopedia
 |
|
|
Flesinoxan
|
|
| Systematic (IUPAC) name | |
| 4-fluoro-N-[2-[4-[(3S)-3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-8-yl]piperazin-1-yl]ethyl]benzamide | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C22H26FN3O4 |
| Mol. mass | 415.458 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Flesinoxan (DU-29373) is an anxiolytic drug which acts as a selective 5-HT1A agonist.[1]
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
[edit] References
- ^ Pitchot W, Wauthy J, Legros JJ, Ansseau M. Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study. European Neuropsychopharmacology. 2004 Mar;14(2):151-5. PMID 15013031
|
||||||||||||||||||||||||||
